Tesla unveiled a new giant 360mwh Megapack energy storage project

China's First Oral COVID-19 Antiviral Medicine in Dispute

An obscure Chinese company called Genuine Biotech(Chinese: 真实生物) was suddenly put under the spotlight on July 25 when the Chinese authority announced the conditional approval of the company's application for adding the treatment of COVID-19 as a new indication of Azvudine under the special review and approval procedures for drug registration.

CRO ClinChoice Raises USD 150 Mn in Series E Round

2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.

Fosun Pharma Net Profit down 45% in Q1 2022 as Value of Financial Assets Slumps

Founded in 1994, Shanghai Fosun Pharma is a global pharmaceutical and health group rooted in China and driven by innovation. Its businesses include pharmaceuticals, medical devices and diagnosis, medical and health services. The group covers the pharmaceutical field through participation in Sinopharm Holdings.

Chinese Inactivated Vaccines against Omicron Variant Approved for Clinical Trial

Will the approval of the inactivated vaccines against Omicron variants help contain the spike in Covid-19 infections across China?

Hillhouse Capital Invested Heavily in Chinese Stocks in Q3 2021

The SEC disclosed Hillhouse Capital's secondary market exposure on November 16.